Publications

HCVERSO1: A Phase Iii Study of Faldaprevir (Fdv) plus Deleobuvir (Dbv) and Ribavirin (Rbv) for Chronic Hcv Genotype (Gt)-1B Infection in Treatment-Naive Patients

AuthID
P-009-ZWT

Author(s)

Sarrazin, C

Castelli, F

Puoti, M

Shiffman, ML

Preotescu, L

Forns, X

Buti, M

Yoshida, EM

Bourliere, M

Oliveira, C

Stern, JO

Boecher, WO

Kukolj, G

Haefner, C

Vinisko, R

Garcia, M

Mensa, FJ

Document Type

Abstract

Year published

2014

Published

in HEPATOLOGY, ISSN: 0270-9139

Volume: 60, Pages: 1150A-1150A (1)

Conference

65Th Annual Meeting of the American-Association-For-The-Study-Of-Liver-Diseases, Date: NOV 07-11, 2014, Location: Boston, MA, Sponsors: Amer Assoc Study Liver Dis

Indexing

Wos^®

Metadata
Sources

Publication Identifiers

Wos: WOS:000344483805034

Source Identifiers

ISSN: 0270-9139

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

HCVERSO1: A Phase Iii Study of Faldaprevir (Fdv) plus Deleobuvir (Dbv) and Ribavirin (Rbv) for Chronic Hcv Genotype (Gt)-1B Infection in Treatment-Naive Patients

Useful Links

Get Help

Federated Authentication (Click on the image)

HCVERSO1: A Phase Iii Study of Faldaprevir (Fdv) plus Deleobuvir (Dbv) and Ribavirin (Rbv) for Chronic Hcv Genotype (Gt)-1B Infection in Treatment-Naive Patients

Useful Links

Get Help